AKR1C1 and cancer: We found that the overall survival time of patients with high levels of AKR1C1 was cut down compared with patients with low levels of AKR1C1 (p = 0.0092) by the Kaplan–Meier analysis, suggesting the specific role of AKR1C1 in cancer metastasis (Figure 3D).